GlassScriptPhysician profile
Robert Michael Tanaka
NPI 1194764720
$6,188.98
in general payments reported to CMS, 2019-2025
24 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,427 · 2020: $1,518 · 2021: $354 · 2022: $184 · 2023: $194 · 2024: $879 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,490 · Consulting Fee: $200 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,489.64 |
| Consulting Fee | $200.00 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,419.12 | 2019-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $1,110.31 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,035.82 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $777.63 | 2019-2025 | Dupixent |
| Genzyme Corporation | $224.52 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $200.00 | 2025 | |
| Intuitive Surgical, INC. | $183.52 | 2022 | |
| Merck Sharp & Dohme LLC | $181.17 | 2019-2025 | Winrevair |
| United Therapeutics Corporation | $129.11 | 2020-2025 | Tyvaso |
| Verona Pharma, INC. | $106.67 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $94.32 | 2019-2025 | Xolair |
| Amgen INC. | $94.24 | 2024-2025 | Tezspire |
| Insmed, INC. | $92.35 | 2025 | Brinsupri, Arikayce |
| Fisher & Paykel Healthcare INC | $88.22 | 2019 | |
| Baxter Healthcare | $75.93 | 2024 | Hillrom - Vest System Model 105 Home Care |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $67.10 | 2019 | |
| Circassia INC. | $63.06 | 2019-2020 | |
| Viatris Specialty LLC | $51.00 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $50.00 | 2020 | |
| Philips North America LLC | $44.57 | 2019-2024 | (8874) Incourage |
| Grifols USA, LLC | $33.08 | 2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $22.75 | 2023 | Inspire |
| Csl Behring | $22.44 | 2024 | Hizentra |
| Gilead Sciences, INC. | $22.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tanaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.